Preclinical CRO Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has entered into a definitive agreement to acquire Celsis International Ltd. for $212 million in cash, subject
Celsis International
Filter by:
Tags
- 23andMe
- 3M
- A1M Pharma
- Abcam
- AbClon
- Ablynx
- Accenture
- ACD Bio
- Actelion
- AdaptImmune
- Advanced Scientifics
- Advicenne
- Aenova
- Aesica
- Affymetrix
- Agilent Technologies
- Agricultural Technology
- Akcea Therapeutics
- Alcami
- Alcor
- Alfa Aesar
- Alkahest
- Alligator Bioscience
- Almac
- Ambrosia
- Amgen
- AMRI
- Annexin Pharmaceuticals
- Applied Genetic Technologies
- Applikon
- argenx
- Arysta LifeScience
- AstraZeneca
- Asymptote
- Athenex
- Atomwise
- Avacta
- Avalanche Biotechnologies
- Avenue Therapeutics
- AveXis
- Avitide
- AzurRx
- Baxalta
- Bayer
- Bayer CropScience
- BD Biosciences
- Beckman Coulter
- Benevolent AI
- Berg Health
- BerGenBio
- Bio-Rad
- Bio-Techne
- Bioarctic B
- Biogen
- BioHaven Pharma
- Bioinformatics
- Biomanufacturing
- Biomarin
- BioOutsource
- Biopharma
- Bioproduction
- BioReliance
- Biotech
- bluebird bio
- Boehringer Ingelheim
- Bonesupport
- Bristol-Myers Squibb
- Cambrex
- Cancer Immunotherapy
- Capsugel
- CAR-T
- CardioCell
- Catalent
- Celgene
- Cell Line Engineering
- Cell Therapy
- Cell Therapy Ltd
- Cellectis
- Celsis International
- Celyad
- Cepheid
- Charles River Laboratories
- ChemChina
- Chemicals
- Clementia Pharmaceuticals
- Clinical Diagnostics
- Clinical Trials
- CMC Biologics
- Cognizant Technology Solutions
- Consort Medical
- Corning
- Covance
- CR Pharma
- Crispr Therapeutics
- CRO/CMO
- Cryonics
- Daiichi Sankyo
- Danaher
- Deciphera Pharmaceuticals
- DeCODE Genetics
- Deloitte
- Denali Therapeutics
- Dendreon
- Diagnostics
- Downstream Processing
- Drug Development
- eGenesis
- Eli Lilly
- Elsevier
- EMD Millipore
- Entegris
- Eris Lifesciences
- Erytech Pharma
- Evidera
- Evolution Global Press Releases
- Evolution Infographics
- Evotec
- Exscientia
- FEI Company
- FiberCell Systems
- FIT Biotech
- Flow Cytometry
- Fosun Pharma
- Fujifilm Diosynth
- G-CON Manufacturing
- G1 Therapeutics
- GE Healthcare
- Gene Therapy
- Genentech
- Genomics & Proteomics
- GenSight Biologics
- Genzyme
- Gilead
- GlaxoSmithKline
- Glycotope
- Google Life Sciences
- Gore
- GSK
- Healthcare Analytics
- IBM
- ICON plc
- Idorsia
- Illumina
- Immunocore
- Immuron
- INC Research
- InDex Pharma
- Inflarx
- Informatics & Analytics
- Infosys
- InSilico Medicine
- InSphero
- inVentiv Health
- Invesco
- IP Group
- Isofol Medical
- JHL Biotech
- JM Separations
- Johnson & Johnson
- Juno Therapeutics
- Juvenescence AI
- Kala Pharmaceuticals
- Kantar Health
- Kerry Group
- KITE Pharma
- KIYATEC
- KrioRus
- Krystal Biotech
- KuBio
- Leica Biosystems
- Life Sciences
- Lion Biotechnologies
- Living Cell Technologies
- Lonza
- McKinsey
- Medical Devices
- Medimmune
- Medivation
- MeiraGTx
- Meissner
- Merck
- Mergers Partnerships & Acquisitions
- Mersana Therapeutics
- Mesoblast
- Metagenomics
- MilliporeSigma
- Modular Factories
- Molecular Pathology
- Monsanto
- Motif Bio
- Mustang Bio
- Myovant Sciences
- Myriad Genetics
- N4 Pharma
- NantKwest
- Natrix Separations
- Navigo Proteins
- Next Generation Sequencing
- Nightstar Therapeutics
- Ningbo Menovo
- Northwest Biotherapeutics
- Nortis
- Novartis
- Novo Nordisk
- NuCana
- Octapharma
- Organovo
- Orphazyme
- Ovid Therapeutics
- Oxford Genetics
- Oxford Nanopore
- Oxford University
- Pacific Biosciences
- Pall
- Parexel
- Patheon
- PerkinElmer
- Pfizer
- Pharmaron
- Plant Impact
- PPD
- Precision Medicine
- Press Ganey
- Prometic Bioseparations
- Promore Pharma
- Puridify
- Qiagen
- QuantiHealth
- Quintiles IMS
- RA Pharmaceuticals
- Regenerative Medicine
- Regeneron
- Repligen
- Roche
- RTI Health Solutions
- Samsung BioLogics
- Sangamo Therapeutics
- Saniona
- Sanofi
- Sartorius Stedim
- Scandinavian Chemotech
- Scarab Genomics
- Seragon
- Shire
- Siegfried
- Sienna Biopharmaceuticals
- Sigma-Aldrich
- Singulex
- SkinBioTherapeutics
- Spark Therapeutics
- Spinout
- Statis Systems
- Stem Cells
- StemoniX
- Stempeutics
- Sudhin Biopharma
- Sunovion Pharma
- Symphony Health Solutions
- Syngenta
- Synthon
- SynVivo
- Takara
- Tanvex BioPharma
- TARA
- Telix Pharma
- Terumo
- Teva Pharmaceuticals
- Texcell
- The Cryonics Institute
- The Future of BioManufacturing
- Theranexus
- Thermo Fisher Scientific
- Thomson Reuters
- TiGenix
- Tocagen
- TOSOH Bioscience
- Touchstone Innovations
- Toxicology
- Truven
- UCB Pharma
- Urogen Pharma
- Valbiotis
- Valeant Pharmaceuticals
- Venture Capital Investment
- Vericel
- Verona Pharma
- Vetter
- Virology
- ViroMed
- Vivo Science
- Wacker
- Waters
- Woodford Fund
- Wuxi Apptec
- WuXi NextCODE
- WuXi PharmaTech
- Xbrane Biopharma
- Xenotransplantation
- Xspray Pharma
- Zai Lab
- Zealand Pharma
- ZellWerk
- Zymeworks
About Us
Evolution Bioscience is a global consultancy firm, specialising in market intelligence, strategy formulation, technology transfer and commercialisation services, covering the full range of Biotechnology sectors.Get In Touch
+44 141 248 2026
Recent Posts
BROWSE NEWS BY INDUSTRY
Agricultural Technology
Biopharma
Bioproduction
Biotech
Cancer Immunotherapy
Cell Therapy
Chemicals
CRO/CMO
Diagnostics
Drug Development
Gene Therapy
Genomics & Proteomics
Informatics & Analytics
Life Sciences
Medical Devices
Mergers Partnerships & Acquisitions
Metagenomics
Next Generation Sequencing
Regenerative Medicine
The Future of BioManufacturing
BROWSE NEWS BY COMPANY
2016 © Evolution Bioscience / Darwin Hutton Partners
Recent Comments